It means there is no established dosing standard, no agreed safety profile for reproductive use, and no clear proof it helps fertility outcomes
It is also approved for use in adults with Type 2 diabetes and established cardiovascular disease because it has shown to reduce the risk of future major cardiovascular events. Conversely, Saxenda is approved for weight loss in adults with a body mass index (BMI) greater than 30 or in patients with a BMI greater than 27 with a weight-related comorbidity, like high blood pressure (hypertension), Type 2 diabetes, or high cholesterol
Common issues may include minor discomfort at the injection site, nausea, dizziness, changes in blood pressure, and skin rashes
You can prescribe it remotely for weight loss as long as you follow Floridas obesity treatment standards (more below)
Drugs able to activate a number of receptors seem to perform better